Advertisement

Topics

NeoImmuneTech Company Profile

19:03 EST 15th December 2018 | BioPortfolio

NeoImmuneTech, a Genexine related company founded in 2014, is focused on leading the development efforts for its flagship immunotherapy product, HyLeukin-7, in the US and EU. Based in Rockville, Maryland, NeoImmuneTech has the core competency of global clinical and business development with a strong scientific focus and a broad network of global leading R&D organizations. NeoImmuneTech is currently conducting Phase 1b/2a clinical trials of HyLeukin-7, aiming at developing not only the first-in-class treatment of lymphopenia but also a breakthrough cancer immunotherapy.


News Articles [5 Associated News Articles listed on BioPortfolio]

NeoImmuneTech Announces Initiation of Clinical Trial for HyLeukin-7 Treatment in Combination ...

Read more...

NeoImmuneTech Announces Initiation of Clinical Trial for HyLeukin-7 Treatment in Combination with Standard Therapy for Newly Diagnosed Brain Cancer Patients

NeoImmuneTech, Inc., an immunotherapy drug development company focused on advanced cancer treatments, today announced the U.S. Food and Drug Administration (FDA) approved i...

NeoImmuneTech Strengthens Senior Management with the Appointment of NgocDiep Le, M.D., Ph.D., as Chief Medical Officer

NeoImmuneTech, Inc., an immunotherapy drug development company focused on advanced cancer treatments, today announced the appointment of NgocDiep (‘Diep’) Le, M.D., Ph....

NeoImmuneTech Presents Hyleukin-7 and Universal CAR-T Combination Therapy Preclinical Data at ASH Annual Meeting

-- Studies in B cell and T cell lymphoma models suggest Hyleukin-7 can significantly enhance and prolong CAR-T activity -- NeoImmuneTech, Inc., an immunotherapy drug de...

Hyleukin-7 Selected as a Korea Drug Development Fund (KDDF) Project for Combination Trial with Merck’s KEYTRUDA®

Genexine, a clinical stage biotechnology company developing innovative biologics, and its spin-off company in the US, NeoImmuneTech, Inc. (NIT), today announced that Hyleukin-7, t...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

NeoImmuneTech

NeoImmuneTech, a Genexine related company founded in 2014, is focused on leading the development efforts for its flagship immunotherapy product, HyLeukin-7, in the US and EU. Base...

NeoImmuneTech, Inc.

NeoImmuneTech (NIT), a Genexine related company founded in 2014, is focused on leading the development efforts for its flagship immunotherapy product, Hyleukin-7, in the U.S. and ...

More Information about "NeoImmuneTech" on BioPortfolio

We have published hundreds of NeoImmuneTech news stories on BioPortfolio along with dozens of NeoImmuneTech Clinical Trials and PubMed Articles about NeoImmuneTech for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NeoImmuneTech Companies in our database. You can also find out about relevant NeoImmuneTech Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record